0.56
0.56 (0.05%)
As of Jun 10, 2022
Zosano Pharma Corp [ZSAN]
Source:
Company Overview
Zosano Pharma Corporation is a clinical-stage biopharmaceutical company focused on providing rapid systemic administration of therapeutics and other bioactive molecules to patients using our proprietary transdermal microneedle system (the “System”). Our System is designed to facilitate rapid drug absorption into the bloodstream, and to provide an improved pharmacokinetic (“PK”) profile compared to original dosage forms.
| Country | United States |
| Headquarters | fremont, california |
| Phone Number | 510-745-1200 |
| Industry | manufacturing |
| CEO | Steven Lo |
| Website | zosanopharma.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $0.1 |
| Operating Profit | $-33.3 |
| Net Income | $-33.4 |
| Net Cash | $2.5 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | -25,240.9 |
| Profit as % of Revenues | -0.1% |
| Profit as % of Assets | -89.3% |
| Profit as % of Stockholder Equity | -237.7% |
Management Effectiveness
| Return on Equity | -237.7% |
| Return on Assets | -126.3% |
| Turnover Ratio | 0.4% |
| EBITA | $-33.3 |
Balance Sheet and Cash Flow Measures
| Total Assets | $26.4 |
| Total Liabilities | $12.4 |
| Operating Cash Flow | $-8.5 |
| Investing Cash Flow | $-0.1 |
| Financing Cash Flow | $11.1 |
